Hexo Corp Fails To Meet NYSE Listing Standards, Mulls Share Consolidation

Hexo Corp (TSX: HEXO) (NYSE: HEXO) has received notification from the New York Stock Exchange that it is not currently in compliance with the continuous listing standards of the exchange. As a result, the company must regain a price of $1.00 per share, for which it is considering all options including a share consolidation.

Now that it has received the notification, Hexo Corp has a six month time frame to regain compliance. This time frame however has been extended due to the ongoing pandemic, with the deadline now extended to December 16, 2020 for Hexo to regain compliance as a result. To do so, it must maintain an average price per share of $1.00 over a thirty day period, while also closing at a price above $1.00 in any given month within the stated period. If compliance is not regained by the end of the period, the NYSE will commence suspension and delisting procedures as a result of not meeting listing standards.

Hexo has indicated that it is considering options to regain compliance, including a share consolidation “if necessary.” Notably, competitor Aurora Cannabis (TSX: ACB) (NYSE: ACB) performed its own share consolidation this week as a means to regain compliance with listing requirements.

Hexo Corp last traded at $0.45 on the NYSE.


Information for this briefing was found via Sedar and Hexo Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027

Mercado Minerals Identifies A Series Of New Targets Following LiDAR Survey At Copalito

Related News

Hexo To Be Acquired By Tilray For US$56.0 Million

It appears that Sebastian St-Louis’s “billion dollar start-up” has finally been sold. Hexo Corp (TSX:...

Monday, April 10, 2023, 05:26:52 PM

Medipharm Labs Scrambles To Instill Investor Confidence

Medipharm Labs (TSX: LABS) appears to be scrambling to quell investor fears, releasing an update...

Thursday, January 30, 2020, 08:29:16 AM

Hexo Corp Sees Strategic Reorganization Push Out CEO, COO

It may have taken several years of declining valuation and a couple questionable transactions, but...

Monday, October 18, 2021, 08:15:15 AM

Hexo Corp To Close Belleville Facility, Impacting 230 Employees

If one thing in the cannabis sector is almost guaranteed, its that Hexo Corp (TSX:...

Friday, April 22, 2022, 07:58:47 AM

Hexo Posts Net Loss of $298.2 Million, Effectively Writes Off Newstrike Transaction

Hexo Corp (TSX: HEXO) (NYSE: HEXO) released its second quarter financials this morning, in what...

Monday, March 30, 2020, 09:00:47 AM